A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03247166 |
Recruitment Status : Unknown
Verified August 2017 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
First Posted : August 11, 2017
Last Update Posted : August 11, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Lower Back Pain | Device: TOPS™ System | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 10 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System |
Estimated Study Start Date : | September 2017 |
Estimated Primary Completion Date : | September 2019 |
Estimated Study Completion Date : | September 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Lower Back and Leg Pain Patients
Patients suffering from lower back and leg pain resulting in degenerative spondylolisthesis and/or spinal stenosis will undergo treatment using the TOPS™ System
|
Device: TOPS™ System
The TOPS™ System is an alternative to spinal fusion that is designed to stabilize but not fuse the effected vertebrai level to alleviate pain stemming from degenerative joints |
- Pain Improvement [ Time Frame: 24 months ]Subjects having a 15% reduction in the Oswestry Low Back Pain Disability Questionnaire score as compared to their preoperative Oswestry score
- Function Improvement [ Time Frame: 24 months ]Subjects having a 15% reduction in the Oswestry Low Back Pain Disability Questionnaire score as compared to their preoperative Oswestry score
- Fusion Prevention [ Time Frame: 24 months ]The subjects will be considered a failure if fusion occurs as defined in the radiographic protocol
- Safety [ Time Frame: 24 months ]Subjects with no serious device complications as defined in the radiological protocol

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with symptomatic monosegmental lumbar spinal stenosis or facet arthrosis
- Patients with degenerative spondylolisthesis
- Patients with at least 3 months failed conservative treatment
- Narrowing of the lumbar spinal canal
- Patients with lower back pain or sciatica
Exclusion Criteria:
- Discogenic back pain at TOPS System level
- Back or non-radicular leg pain of unknown etiology at TOPS System level
- Lytic spondylolisthesis at TOPS System level
- More than one motion segment involved in degenerative pathology to the extent that justifies its inclusion in the surgical procedure
- Known allergy to titanium and/or polyurethane

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03247166
Contact: Ilana Alony, RN | 972-4-6304487 | ilanaa@hy.health.gov.il |
Israel | |
Hillel Yaffe Medical Center | |
H̱adera, Israel, 38100 | |
Contact: Ilana Alony, RN 972-4-6304487 ilanaa@hy.health.gov.il |
Principal Investigator: | Eyal Behrbalk, MD | Hillel Yaffe Medical Center |
Responsible Party: | Hillel Yaffe Medical Center |
ClinicalTrials.gov Identifier: | NCT03247166 |
Other Study ID Numbers: |
HYMC-36-17 |
First Posted: | August 11, 2017 Key Record Dates |
Last Update Posted: | August 11, 2017 |
Last Verified: | August 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Low Back Pain Back Pain Pain Neurologic Manifestations |